BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 18332153)

  • 1. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
    Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
    Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
    Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function.
    Nelson CL; Karschimkus CS; Dragicevic G; Packham DK; Wilson AM; O'Neal D; Becker GJ; Best JD; Jenkins AJ
    Nephrol Dial Transplant; 2005 Nov; 20(11):2420-6. PubMed ID: 16115854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes.
    Bangstad HJ; Seljeflot I; Berg TJ; Hanssen KF
    Scand J Clin Lab Invest; 2009; 69(1):138-44. PubMed ID: 18846477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
    Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
    Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss.
    Martos R; Valle M; Morales RM; Cañete R; Gascón F; Urbano MM
    Metabolism; 2009 Aug; 58(8):1153-60. PubMed ID: 19477472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes.
    Nelson SM; Sattar N; Freeman DJ; Walker JD; Lindsay RS
    Diabetes; 2007 Nov; 56(11):2697-704. PubMed ID: 17704300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus.
    Shestakova MV; Jarek-Martynowa IR; Ivanishina NS; Kuharenko SS; Yadrihinskaya MN; Aleksandrov AA; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S65-72. PubMed ID: 15955379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M; Tarnow L; Jorsal A; Parving HH
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
    Hovind P; Tarnow L; Rossing P; Teerlink T; Stehouwer CD; Emeis JJ; Parving HH
    Am J Kidney Dis; 2001 Dec; 38(6):1376-80. PubMed ID: 11728978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
    Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients.
    van Ree RM; Oterdoom LH; de Vries AP; Homan van der Heide JJ; van Son WJ; Navis G; Gans RO; Bakker SJ
    Transplantation; 2008 Dec; 86(12):1713-9. PubMed ID: 19104410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy.
    Taslipinar A; Yaman H; Yilmaz MI; Demirbas S; Saglam M; Taslipinar MY; Agilli M; Kurt YG; Sonmez A; Azal O; Bolu E; Yenicesu M; Kutlu M
    Scand J Clin Lab Invest; 2011 Nov; 71(7):606-12. PubMed ID: 21864054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
    Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
    Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
    Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes.
    Zoppini G; Targher G; Zamboni C; Venturi C; Cacciatori V; Moghetti P; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Dec; 16(8):543-9. PubMed ID: 17126770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study.
    van Bussel BC; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Stehouwer CD
    J Hypertens; 2012 Apr; 30(4):744-52. PubMed ID: 22343535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.